UNSPSC 51142423: Almotriptan malate

This classification denotes a serotonin agonist with the molecular formula C17H25N3O2S.C4H6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PJP312605E, chemically known as 1-(((3-(2-(dimethylamino)ethyl)-1h-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedionate (1:1) but more generally known as almotriptan malate, which bears US NIH Compound Identifier 123607. The base compound, Almotriptan, comes in base and malate forms.

UNSPSC 51142423 Almotriptan malate is a Commodity code for a specific migraine medication. State and local procurement activity under this code does not align with the recent opportunities posted in the source; the three most recent solicitations involve naloxone and drug deactivation systems, a direct-to-manufacturer prescription program pilot, and multi-source generic pharmaceuticals and OTC products through a cooperative purchasing alliance. None of these solicitations specifically target almotriptan malate or migraine treatments. The code shows no directly relevant recent state and local procurement activity.

The mismatch between the code's pharmaceutical scope and the actual recent opportunities suggests either that almotriptan malate procurement by state and local bodies is minimal or that issuing agencies are not tagging such purchases under this specific commodity code. Firms pursuing state and local pharmaceutical opportunities should monitor broader family-level codes covering generic pharmaceuticals, cooperative purchasing arrangements like MMCAP, and state health agency RFPs rather than expect activity to surface consistently at the almotriptan-specific commodity tier.